(Reuters) - Synairgen Plc (SYNG.L) said on Monday its drug helped reduce the risk of severe cases in hospitalised patients with COVID-19, according to data from a trial of more than 100 people in the United Kingdom, sending its shares skyrocketing. The trial, which used interferon beta, showed that patients who were given Synairgen’s formulation…
4 min read THERE'S BEEN A wave of new therapies for Alzheimer’s disease released over the last few years. But nothing would be as revolutionary as simply taking a pill to slow down cognitive decline. Better yet, the ideal medication would be a pill that could protect people with a genetic risk for Alzheimer's. That's
Please complete security verification This request seems a bit unusual, so we need to confirm that you're human. Please press and hold the button until it turns completely green. Thank you for your cooperation! Press and hold the button If you believe this is an error, please contact our support team. 185.149.70.50 : 94115c96-73fb-461e-9924-a7783076
You don't have permission to access "http://www.cpsc.gov/Recalls/2026/Modera-Recalls-Modera-Pack-N-Play-Mattresses-Due-to-Risk-of-Serious-Injury-or-Death-from-Entrapment-Violates-Mandatory-Standard-for-Crib-Mattresses" on this server. Reference #18.cbd7ce17.1761984108.31aa9760 https://errors.edgesuite.net/18.cbd7ce17.1761984108.31aa9760